Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
Medicare might cover dental care as part of large budget bill, NY Times reports » 09:49
08/30/21
08/30
09:49
08/30/21
09:49
SDC

SmileDirectClub

$5.33 /

+0.155 (+3.00%)

, HSIC

Henry Schein

$75.25 /

+0.02 (+0.03%)

, NVST

Envista

$42.82 /

+0.14 (+0.33%)

, PDCO

Patterson Companies

$30.25 /

-0.03 (-0.10%)

, XRAY

Dentsply Sirona

$62.18 /

+0.08 (+0.13%)

, ALGN

Align Technology

$706.51 /

+4.81 (+0.69%)

Tens of millions of older…

Tens of millions of older Americans who cannot afford dental care - with severe consequences for their overall health, what they eat and even when they smile - may soon get help as Democrats maneuver to add dental benefits to Medicare for the first time in its history, The New York Times' Margot Sanger-Katz reports. The proposal, part of the large budget bill moving through Congress, would be among the largest changes to Medicare since its creation in 1965 but would require overcoming resistance from dentists themselves, who are worried that it would pay them too little, the author notes. Publicly traded companies in the space include Align (ALGN), SmileDirectClub (SDC), Henry Schein (HSIC), Envista (NVST), Patterson Companies (PDCO) and Dentsply Sirona (XRAY). Reference Link

ShowHide Related Items >><<
XRAY Dentsply Sirona
$62.18 /

+0.08 (+0.13%)

SDC SmileDirectClub
$5.33 /

+0.155 (+3.00%)

PDCO Patterson Companies
$30.25 /

-0.03 (-0.10%)

NVST Envista
$42.82 /

+0.14 (+0.33%)

HSIC Henry Schein
$75.25 /

+0.02 (+0.03%)

ALGN Align Technology
$706.51 /

+4.81 (+0.69%)

SDC SmileDirectClub
$5.33 /

+0.155 (+3.00%)

08/13/21
Fly Intel: Top five analyst downgrades
08/13/21 Wolfe Research
SmileDirectClub downgraded to Peer Perform from Outperform at Wolfe Research
08/10/21
Fly Intel: Top five analyst downgrades
08/10/21 Loop Capital
SmileDirectClub price target lowered to $6 from $9 at Loop Capital
HSIC Henry Schein
$75.25 /

+0.02 (+0.03%)

08/05/21 Credit Suisse
Henry Schein assumed with a Neutral at Credit Suisse
08/04/21 Barrington
Henry Schein price target raised to $95 from $91 at Barrington
08/03/21 Piper Sandler
Henry Schein price target raised to $95 from $89 at Piper Sandler
07/14/21 Piper Sandler
Dental for Medicare beneficiaries would be 'solid tailwind,' says Piper
NVST Envista
$42.82 /

+0.14 (+0.33%)

08/10/21 Goldman Sachs
SmileDirectClub price target lowered to $4 from $7 at Goldman Sachs
08/05/21 Credit Suisse
Envista assumed with an Outperform at Credit Suisse
08/04/21 Piper Sandler
Envista price target raised to $47 from $45 at Piper Sandler
PDCO Patterson Companies
$30.25 /

-0.03 (-0.10%)

08/05/21
Fly Intel: Top five analyst initiations
08/05/21 Credit Suisse
Patterson Companies assumed with an Outperform at Credit Suisse
06/24/21 Baird
Patterson Companies price target lowered to $35 from $37 at Baird
XRAY Dentsply Sirona
$62.18 /

+0.08 (+0.13%)

08/09/21 H.C. Wainwright
Dentsply Sirona price target lowered to $66 from $72 at H.C. Wainwright
08/06/21 Barrington
Dentsply Sirona price target raised to $79 from $77 at Barrington
08/06/21 Piper Sandler
Dentsply Sirona weakness a buying opportunity, says Piper Sandler
ALGN Align Technology
$706.51 /

+4.81 (+0.69%)

08/05/21 Credit Suisse
Align Technology assumed with an Outperform at Credit Suisse
07/29/21 Credit Suisse
Align Technology price target raised to $732 from $715 at Credit Suisse
07/29/21 Piper Sandler
Align Technology price target raised to $775 from $735 at Piper Sandler
XRAY Dentsply Sirona
$62.18 /

+0.08 (+0.13%)

SDC SmileDirectClub
$5.33 /

+0.155 (+3.00%)

PDCO Patterson Companies
$30.25 /

-0.03 (-0.10%)

NVST Envista
$42.82 /

+0.14 (+0.33%)

HSIC Henry Schein
$75.25 /

+0.02 (+0.03%)

ALGN Align Technology
$706.51 /

+4.81 (+0.69%)

  • 24
    Nov
  • 19
    Nov
SDC SmileDirectClub
$5.33 /

+0.155 (+3.00%)

PDCO Patterson Companies
$30.25 /

-0.03 (-0.10%)

NVST Envista
$42.82 /

+0.14 (+0.33%)

ALGN Align Technology
$706.51 /

+4.81 (+0.69%)

SDC SmileDirectClub
$5.33 /

+0.155 (+3.00%)

ALGN Align Technology
$706.51 /

+4.81 (+0.69%)

Hot Stocks
NAIA announces partnership with Henry Schein Medical » 18:21
08/26/21
08/26
18:21
08/26/21
18:21
HSIC

Henry Schein

$74.11 /

-1.445 (-1.91%)

The National Association…

The National Association of Intercollegiate Athletics announced that it has come to terms with Henry Schein Medical, the medical business of Henry Schein, as its 'Official Sports Medicine Partner' through June 2022. The one year agreement will provide NAIA members a discounted rate for sports medicine services on their campuses, giving institutions an affordable option of medical services for their student-athletes. Supplies can be selected from a variety of product categories offered by Henry Schein Medical's Athletics & Schools business, including: infection control, hot and cold therapy treatment, physical therapy equipment, athletic tapes and bandages, rehydration, and nutrition. Additionally, Henry Schein Medical's Athletics & Schools business will provide athletic training supplies for all NAIA Championships.

ShowHide Related Items >><<
HSIC Henry Schein
$74.11 /

-1.445 (-1.91%)

HSIC Henry Schein
$74.11 /

-1.445 (-1.91%)

08/05/21 Credit Suisse
Henry Schein assumed with a Neutral at Credit Suisse
08/04/21 Barrington
Henry Schein price target raised to $95 from $91 at Barrington
08/03/21 Piper Sandler
Henry Schein price target raised to $95 from $89 at Piper Sandler
07/14/21 Piper Sandler
Dental for Medicare beneficiaries would be 'solid tailwind,' says Piper
HSIC Henry Schein
$74.11 /

-1.445 (-1.91%)

Over a month ago
Initiation
Henry Schein assumed with a Neutral at Credit Suisse » 07:15
08/05/21
08/05
07:15
08/05/21
07:15
HSIC

Henry Schein

$77.32 /

-3.07 (-3.82%)

Credit Suisse analyst Vik…

Credit Suisse analyst Vik Chopra assumed coverage of Henry Schein with a Neutral rating and $78 price target. The analyst made no changes to the firm's rating, target price or estimates at this time.

ShowHide Related Items >><<
HSIC Henry Schein
$77.32 /

-3.07 (-3.82%)

HSIC Henry Schein
$77.32 /

-3.07 (-3.82%)

08/04/21 Barrington
Henry Schein price target raised to $95 from $91 at Barrington
08/03/21 Piper Sandler
Henry Schein price target raised to $95 from $89 at Piper Sandler
07/14/21 Piper Sandler
Dental for Medicare beneficiaries would be 'solid tailwind,' says Piper
05/05/21 Barrington
Henry Schein price target raised to $91 from $80 at Barrington
HSIC Henry Schein
$77.32 /

-3.07 (-3.82%)

Recommendations
Henry Schein price target raised to $95 from $91 at Barrington » 08:07
08/04/21
08/04
08:07
08/04/21
08:07
HSIC

Henry Schein

$80.30 /

-0.99 (-1.22%)

Barrington analyst…

Barrington analyst Michael Petusky raised the firm's price target on Henry Schein to $95 from $91 and keeps an Outperform rating on the shares following the "sizeable" Q2 beat. The analyst views the company's fiscal 2021 earnings outlook as "unrealistically pessimistic."

ShowHide Related Items >><<
HSIC Henry Schein
$80.30 /

-0.99 (-1.22%)

HSIC Henry Schein
$80.30 /

-0.99 (-1.22%)

08/03/21 Piper Sandler
Henry Schein price target raised to $95 from $89 at Piper Sandler
07/14/21 Piper Sandler
Dental for Medicare beneficiaries would be 'solid tailwind,' says Piper
05/05/21 Barrington
Henry Schein price target raised to $91 from $80 at Barrington
05/05/21 Baird
Henry Schein price target raised to $90 from $79 at Baird
HSIC Henry Schein
$80.30 /

-0.99 (-1.22%)

Conference/Events
Henry Schein management to meet virtually with Oppenheimer » 04:55
08/04/21
08/04
04:55
08/04/21
04:55
HSIC

Henry Schein

$80.30 /

-0.99 (-1.22%)

Virtual Meeting to be…

Virtual Meeting to be held on August 4 hosted by Oppenheimer.

ShowHide Related Items >><<
HSIC Henry Schein
$80.30 /

-0.99 (-1.22%)

HSIC Henry Schein
$80.30 /

-0.99 (-1.22%)

08/03/21 Piper Sandler
Henry Schein price target raised to $95 from $89 at Piper Sandler
07/14/21 Piper Sandler
Dental for Medicare beneficiaries would be 'solid tailwind,' says Piper
05/05/21 Barrington
Henry Schein price target raised to $91 from $80 at Barrington
05/05/21 Baird
Henry Schein price target raised to $90 from $79 at Baird
HSIC Henry Schein
$80.30 /

-0.99 (-1.22%)

Recommendations
Henry Schein price target raised to $95 from $89 at Piper Sandler » 14:11
08/03/21
08/03
14:11
08/03/21
14:11
HSIC

Henry Schein

$79.32 /

-1.97 (-2.42%)

Piper Sandler analyst…

Piper Sandler analyst Jason Bednar raised the firm's price target on Henry Schein to $95 from $89 and keeps an Overweight rating on the shares. The analyst notes the company reported Q2 results that had the all-important dental franchise drive upside versus consensus revenue as dental patient volumes have returned near pre-COVID levels. While shares are giving back some recent gains in trading on Tuesday, Bednar comes away from its earnings conference call and results with greater confidence in Henry Schein's near- to intermediate-term outlook and expects shares to continue narrowing their relative multiple discount versus the S&P over the next 6-12 months.

ShowHide Related Items >><<
HSIC Henry Schein
$79.32 /

-1.97 (-2.42%)

HSIC Henry Schein
$79.32 /

-1.97 (-2.42%)

07/14/21 Piper Sandler
Dental for Medicare beneficiaries would be 'solid tailwind,' says Piper
05/05/21 Barrington
Henry Schein price target raised to $91 from $80 at Barrington
05/05/21 Baird
Henry Schein price target raised to $90 from $79 at Baird
05/04/21 Piper Sandler
Henry Schein price target raised to $89 from $79 at Piper Sandler
HSIC Henry Schein
$79.32 /

-1.97 (-2.42%)

Earnings
Henry Schein sees FY21 adjusted continuing ops EPS above $3.85, consensus $4.14 » 06:33
08/03/21
08/03
06:33
08/03/21
06:33
HSIC

Henry Schein

$81.27 /

+1.09 (+1.36%)

2021 non-GAAP diluted EPS…

2021 non-GAAP diluted EPS from continuing operations attributable to Henry Schein, Inc. is now expected to be at or above $3.85, representing a floor for fiscal 2021. This compares with previous guidance for non-GAAP diluted EPS from continuing operations attributable to Henry Schein, Inc. to be at or above $3.70.

ShowHide Related Items >><<
HSIC Henry Schein
$81.27 /

+1.09 (+1.36%)

HSIC Henry Schein
$81.27 /

+1.09 (+1.36%)

07/14/21 Piper Sandler
Dental for Medicare beneficiaries would be 'solid tailwind,' says Piper
05/05/21 Barrington
Henry Schein price target raised to $91 from $80 at Barrington
05/05/21 Baird
Henry Schein price target raised to $90 from $79 at Baird
05/04/21 Piper Sandler
Henry Schein price target raised to $89 from $79 at Piper Sandler
HSIC Henry Schein
$81.27 /

+1.09 (+1.36%)

Earnings
Henry Schein reports Q2 adjusted continuing ops EPS $1.11, consensus 97c » 06:32
08/03/21
08/03
06:32
08/03/21
06:32
HSIC

Henry Schein

$81.27 /

+1.09 (+1.36%)

Reports Q2 revenue $3B,…

Reports Q2 revenue $3B, consensus $2.89B. "We are pleased to report record second-quarter financial results as we continue to execute on our key strategies. Strengthening demand in the global dental and medical markets drove strong year-over-year increases in sales versus the prior year when many of our customers had temporarily closed their offices. Notably, compared with a pre-COVID-19 environment in the second quarter of 2019, Henry Schein's worldwide internal sales in local currencies increased by 15.2%," said Stanley M. Bergman, Chairman of the Board and CEO of Henry Schein. "We are also pleased with operating margin expansion that reflects a favorable product mix as well as operating expense leverage."

ShowHide Related Items >><<
HSIC Henry Schein
$81.27 /

+1.09 (+1.36%)

HSIC Henry Schein
$81.27 /

+1.09 (+1.36%)

07/14/21 Piper Sandler
Dental for Medicare beneficiaries would be 'solid tailwind,' says Piper
05/05/21 Barrington
Henry Schein price target raised to $91 from $80 at Barrington
05/05/21 Baird
Henry Schein price target raised to $90 from $79 at Baird
05/04/21 Piper Sandler
Henry Schein price target raised to $89 from $79 at Piper Sandler
HSIC Henry Schein
$81.27 /

+1.09 (+1.36%)

Conference/Events
Henry Schein management to meet virtually with Oppenheimer » 16:10
07/27/21
07/27
16:10
07/27/21
16:10
HSIC

Henry Schein

$78.57 /

+1.19 (+1.54%)

Virtual Meeting to be…

Virtual Meeting to be held on August 4 hosted by Oppenheimer.

ShowHide Related Items >><<
HSIC Henry Schein
$78.57 /

+1.19 (+1.54%)

HSIC Henry Schein
$78.57 /

+1.19 (+1.54%)

07/14/21 Piper Sandler
Dental for Medicare beneficiaries would be 'solid tailwind,' says Piper
05/05/21 Barrington
Henry Schein price target raised to $91 from $80 at Barrington
05/05/21 Baird
Henry Schein price target raised to $90 from $79 at Baird
05/04/21 Piper Sandler
Henry Schein price target raised to $89 from $79 at Piper Sandler
HSIC Henry Schein
$78.57 /

+1.19 (+1.54%)

Recommendations
Dental for Medicare beneficiaries would be 'solid tailwind,' says Piper » 09:16
07/14/21
07/14
09:16
07/14/21
09:16
HSIC

Henry Schein

$76.36 /

-0.61 (-0.79%)

, NVST

Envista

$42.87 /

-1.205 (-2.73%)

, PDCO

Patterson Companies

$30.03 /

-0.35 (-1.15%)

, XRAY

Dentsply Sirona

$61.98 /

-0.69 (-1.10%)

Multiple reports…

Multiple reports overnight indicate that dental coverage for Medicare beneficiaries is part of the $3.5 trillion spending plan announced last night by the Senate Budget Committee, Piper Sandler analyst Jason Bednar tells investors in a research note. The analyst believes this "has the potential to be one of the more impactful pieces" of legislation for the U.S. dental industry in years. Dental investors should keep a close eye on the progression of the spending plan as dental coverage for Medicare-aged individuals could ultimately be a "solid tailwind" to total dental care spending if implemented, benefiting the entire group of diversified dental manufacturers and distributors, says Bednar. The analyst covers four dental names that have exposure to general dental care in the U.S: Henry Schein (HSIC), Envista (NVST), Patterson Companies (PDCO) and Dentsply Sirona (XRAY).

ShowHide Related Items >><<
XRAY Dentsply Sirona
$61.98 /

-0.69 (-1.10%)

PDCO Patterson Companies
$30.03 /

-0.35 (-1.15%)

NVST Envista
$42.87 /

-1.205 (-2.73%)

HSIC Henry Schein
$76.36 /

-0.61 (-0.79%)

HSIC Henry Schein
$76.36 /

-0.61 (-0.79%)

05/05/21 Barrington
Henry Schein price target raised to $91 from $80 at Barrington
05/05/21 Baird
Henry Schein price target raised to $90 from $79 at Baird
05/04/21 Piper Sandler
Henry Schein price target raised to $89 from $79 at Piper Sandler
05/04/21 Piper Sandler
Henry Schein should be bought into earnings rally, says Piper Sandler
NVST Envista
$42.87 /

-1.205 (-2.73%)

05/06/21 Credit Suisse
Envista price target raised to $55 from $49 at Credit Suisse
05/06/21 Piper Sandler
Envista price target raised to $45 from $41 at Piper Sandler
02/11/21 Piper Sandler
Envista price target raised to $41 from $28 at Piper Sandler
01/08/21 Credit Suisse
Envista upgraded to Outperform from Neutral at Credit Suisse
PDCO Patterson Companies
$30.03 /

-0.35 (-1.15%)

06/24/21 Baird
Patterson Companies price target lowered to $35 from $37 at Baird
06/23/21 Piper Sandler
Patterson Companies price target lowered to $41 from $44 at Piper Sandler
06/23/21 Piper Sandler
Patterson earnings pullback a buying opportunity, says Piper Sandler
06/17/21
Fly Intel: Top five analyst upgrades
XRAY Dentsply Sirona
$61.98 /

-0.69 (-1.10%)

06/21/21 Piper Sandler
Piper uncovers 'solid strategic and financial win' for Dentsply Sirona
05/07/21 Barrington
Dentsply Sirona price target raised to $77 from $71 at Barrington
05/07/21 Baird
Dentsply Sirona price target raised to $78 from $71 at Baird
05/07/21 H.C. Wainwright
Dentsply Sirona price target raised to $72 from $60 at H.C. Wainwright
XRAY Dentsply Sirona
$61.98 /

-0.69 (-1.10%)

PDCO Patterson Companies
$30.03 /

-0.35 (-1.15%)

NVST Envista
$42.87 /

-1.205 (-2.73%)

HSIC Henry Schein
$76.36 /

-0.61 (-0.79%)

XRAY Dentsply Sirona
$61.98 /

-0.69 (-1.10%)

PDCO Patterson Companies
$30.03 /

-0.35 (-1.15%)

NVST Envista
$42.87 /

-1.205 (-2.73%)

XRAY Dentsply Sirona
$61.98 /

-0.69 (-1.10%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.